CooperCompanies announced a 10% increase in revenue to $930.2 million. GAAP diluted EPS was $1.71, while non-GAAP diluted EPS reached $3.35. The company's performance was driven by strong results from both CooperVision and CooperSurgical.
Revenue increased by 10% year-over-year to $930.2 million.
CooperVision revenue was up 11% to $630.2 million.
CooperSurgical revenue increased by 8% to $300.0 million.
Non-GAAP diluted EPS increased by 5% to $3.35.
The Company updated its fiscal year 2023 financial guidance. Fiscal 2023 total revenue of $3,578 - $3,595 million (organic growth of 9% to 10%). Fiscal 2023 non-GAAP diluted earnings per share of $12.72 - $12.90.
Visualization of income flow from segment revenue to net income